| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 7, 1266-1274, Copyright © 1993 by Endocrine Society
ARTICLES |
JM Beekman, GF Allan, SY Tsai, MJ Tsai and BW O'Malley
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.
The estrogen receptor (ER) is a strong hormone-inducible transcription factor that regulates the expression of many genes. It was shown for the human progesterone receptor that the binding of hormone causes distinct conformational changes in the ligand binding domain (LBD) and that these changes in LBD conformation are crucial for events after DNA binding. We now show that conformational changes in the LBD of the human ER are a prerequisite for trans-activation. Under the appropriate conditions ER binds to its response element and activates transcription only in the presence of ligand. Binding of the ligand causes changes in the conformation of the LBD. Antihormones induce distinct conformational changes, the differences between the conformations lying in the carboxy-terminal end of the receptor. Changing the experimental conditions results in a receptor that can bind to DNA and activate transcription in a ligand-independent manner. Under these conditions the LBD has a transcriptionally active conformation in the absence of ligand. Taken together, our data indicate that the conformational change induced by ligand is required for converting a receptor to the transcriptionally active form.
This article has been cited by other articles:
![]() |
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies Endocr. Rev., October 1, 2006; 27(6): 575 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Keay, J. T. Bridgham, and J. W. Thornton The Octopus vulgaris Estrogen Receptor Is a Constitutive Transcriptional Activator: Evolutionary and Functional Implications Endocrinology, August 1, 2006; 147(8): 3861 - 3869. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J Butt, C. M McNeil, E. A Musgrove, and R. L Sutherland Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E Endocr. Relat. Cancer, July 1, 2005; 12(Supplement_1): S47 - S59. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. McDonnell The Molecular Pharmacology of Estrogen Receptor Modulators: Implications for the Treatment of Breast Cancer Clin. Cancer Res., January 15, 2005; 11(2): 871s - 877s. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Smith and B. W. O'Malley Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev., February 1, 2004; 25(1): 45 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, N. K. Shevde, A. Warrier, L. A. Plum, H. F. DeLuca, and J. W. Pike 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 Potently Stimulates Gene-specific DNA Binding of the Vitamin D Receptor in Osteoblasts J. Biol. Chem., August 22, 2003; 278(34): 31756 - 31765. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Hsu, Y.-L. Chen, S. Yeh, H.-J. Ting, Y.-C. Hu, H. Lin, X. Wang, and C. Chang The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature Motifs J. Biol. Chem., June 20, 2003; 278(26): 23691 - 23698. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Miner, C. Tyree, J. Hu, E. Berger, K. Marschke, M. Nakane, M. J. Coghlan, D. Clemm, B. Lane, and J. Rosen A Nonsteroidal Glucocorticoid Receptor Antagonist Mol. Endocrinol., January 1, 2003; 17(1): 117 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yi, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan Differences in the Abilities of Estrogen Receptors to Integrate Activation Functions Are Critical for Subtype-Specific Transcriptional Responses Mol. Endocrinol., August 1, 2002; 16(8): 1810 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yi, M. D. Driscoll, J. Huang, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan The Effects of Estrogen-Responsive Element- and Ligand-Induced Structural Changes on the Recruitment of Cofactors and Transcriptional Responses by ER{alpha} and ER{beta} Mol. Endocrinol., April 1, 2002; 16(4): 674 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Branham, S. L. Dial, C. L. Moland, B. S. Hass, R. M. Blair, H. Fang, L. Shi, W. Tong, R. G. Perkins, and D. M. Sheehan Phytoestrogens and Mycoestrogens Bind to the Rat Uterine Estrogen Receptor J. Nutr., April 1, 2002; 132(4): 658 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. McDonnell, C. E. Connor, A. Wijayaratne, C.-y. Chang, and J. D. Norris Definition of the Molecular and Cellular Mechanisms Underlying the Tissue-selective Agonist/Antagonist Activities of Selective Estrogen Receptor Modulators Recent Prog. Horm. Res., January 1, 2002; 57(1): 295 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Metivier, G. Penot, G. Flouriot, and F. Pakdel Synergism Between ER{alpha} Transactivation Function 1 (AF-1) and AF-2 Mediated by Steroid Receptor Coactivator Protein-1: Requirement for the AF-1 {alpha}-Helical Core and for a Direct Interaction Between the N- and C-Terminal Domains Mol. Endocrinol., November 1, 2001; 15(11): 1953 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Nagel, J. L. Hagelbarger, and D. P. McDonnell Development of an ER Action Indicator Mouse for the Study of Estrogens, Selective ER Modulators (SERMs), and Xenobiotics Endocrinology, November 1, 2001; 142(11): 4721 - 4728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson Mechanisms of Estrogen Action Physiol Rev, October 1, 2001; 81(4): 1535 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wood, V. S. Likhite, M. A. Loven, and A. M. Nardulli Allosteric Modulation of Estrogen Receptor Conformation by Different Estrogen Response Elements Mol. Endocrinol., July 1, 2001; 15(7): 1114 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. G. W. Fleming, Y. Choi, G. A. Johnson, T. E. Spencer, and F. W. Bazer Cloning of the Ovine Estrogen Receptor-{{alpha}} Promoter and Functional Regulation by Ovine Interferon-{{tau}} Endocrinology, July 1, 2001; 142(7): 2879 - 2887. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zilliacus, E. Holter, H. Wakui, H. Tazawa, E. Treuter, and J.-A. Gustafsson Regulation of Glucocorticoid Receptor Activity by 14-3-3-Dependent Intracellular Relocalization of the Corepressor RIP140 Mol. Endocrinol., April 1, 2001; 15(4): 501 - 511. [Abstract] [Full Text] |
||||
![]() |
M. J. Weyant, A. M. Carothers, N. N. Mahmoud, H. L. Bradlow, H. Remotti, R. T. Bilinski, and M. M. Bertagnolli Reciprocal Expression of ER{{alpha}} and ER{beta} Is Associated with Estrogen-mediated Modulation of Intestinal Tumorigenesis Cancer Res., March 1, 2001; 61(6): 2547 - 2551. [Abstract] [Full Text] |
||||
![]() |
C. M. Bula, J. E. Bishop, S. Ishizuka, and A. W. Norman 25-Dehydro-1{alpha}-Hydroxyvitamin D3- 26,23S-Lactone Antagonizes the Nuclear Vitamin D Receptor by Mediating a Unique Noncovalent Conformational Change Mol. Endocrinol., November 1, 2000; 14(11): 1788 - 1796. [Abstract] [Full Text] |
||||
![]() |
R. Métivier, F. G. Petit, Y. Valotaire, and F. Pakdel Function of N-Terminal Transactivation Domain of the Estrogen Receptor Requires a Potential {alpha}-Helical Structure and Is Negatively Regulated by the A Domain Mol. Endocrinol., November 1, 2000; 14(11): 1849 - 1871. [Abstract] [Full Text] |
||||
![]() |
S. Cote, D. Zhou, A. Bianchini, C. Nervi, R. E. Gallagher, and W. H. Miller Jr Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia Blood, November 1, 2000; 96(9): 3200 - 3208. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Blair, H. Fang, W. S. Branham, B. S. Hass, S. L. Dial, C. L. Moland, W. Tong, L. Shi, R. Perkins, and D. M. Sheehan The Estrogen Receptor Relative Binding Affinities of 188 Natural and Xenochemicals: Structural Diversity of Ligands Toxicol. Sci., March 1, 2000; 54(1): 138 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Wijayaratne, S. C. Nagel, L. A. Paige, D. J. Christensen, J. D. Norris, D. M. Fowlkes, and D. P. McDonnell Comparative Analyses of Mechanistic Differences Among Antiestrogens Endocrinology, December 1, 1999; 140(12): 5828 - 5840. [Abstract] [Full Text] |
||||
![]() |
T. Gao, K. Brantley, E. Bolu, and M. J. McPhaul RFG (ARA70, ELE1) Interacts with the Human Androgen Receptor in a Ligand-Dependent Fashion, but Functions Only Weakly as a Coactivator in Cotransfection Assays Mol. Endocrinol., October 1, 1999; 13(10): 1645 - 1656. [Abstract] [Full Text] |
||||
![]() |
M. J. Tetel, P. H. Giangrande, S. A. Leonhardt, D. P. McDonnell, and D. P. Edwards Hormone-Dependent Interaction between the Amino- and Carboxyl-Terminal Domains of Progesterone Receptor in Vitro and in Vivo Mol. Endocrinol., June 1, 1999; 13(6): 910 - 924. [Abstract] [Full Text] |
||||
![]() |
S. Roux, B. Terouanne, B. Couette, M.-E. Rafestin-Oblin, and J.-C. Nicolas Conformational Change in the Human Glucocorticoid Receptor Induced by Ligand Binding Is Altered by Mutation of Isoleucine 747 by a Threonine J. Biol. Chem., April 9, 1999; 274(15): 10059 - 10065. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Paige, D. J. Christensen, H. Gron, J. D. Norris, E. B. Gottlin, K. M. Padilla, C.-y. Chang, L. M. Ballas, P. T. Hamilton, D. P. McDonnell, et al. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta PNAS, March 30, 1999; 96(7): 3999 - 4004. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Nawaz, D. M. Lonard, A. P. Dennis, C. L. Smith, and B. W. O'Malley Proteasome-dependent degradation of the human estrogen receptor PNAS, March 2, 1999; 96(5): 1858 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu and D. B. DeFranco Chromatin Recycling of Glucocorticoid Receptors: Implications for Multiple Roles of Heat Shock Protein 90 Mol. Endocrinol., March 1, 1999; 13(3): 355 - 365. [Abstract] [Full Text] |
||||
![]() |
G. A. Peters and S. A. Khan Estrogen Receptor Domains E and F: Role in Dimerization and Interaction with Coactivator RIP-140 Mol. Endocrinol., February 1, 1999; 13(2): 286 - 296. [Abstract] [Full Text] |
||||
![]() |
E. M. McInerney, D. W. Rose, S. E. Flynn, S. Westin, T.-M. Mullen, A. Krones, J. Inostroza, J. Torchia, R. T. Nolte, N. Assa-Munt, et al. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation Genes & Dev., November 1, 1998; 12(21): 3357 - 3368. [Abstract] [Full Text] |
||||
![]() |
S. Kim-Schulze, W. L. Lowe Jr, and H. W. Schnaper Estrogen Stimulates Delayed Mitogen-Activated Protein Kinase Activity in Human Endothelial Cells via an Autocrine Loop That Involves Basic Fibroblast Growth Factor Circulation, August 4, 1998; 98(5): 413 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Barkhem, B. Carlsson, Y. Nilsson, E. Enmark, J.-A. Gustafsson, and S. Nilsson Differential Response of Estrogen Receptor alpha and Estrogen Receptor beta to Partial Estrogen Agonists/Antagonists Mol. Pharmacol., July 1, 1998; 54(1): 105 - 112. [Abstract] [Full Text] |
||||
![]() |
I. G. Schulman, G. Shao, and R. A. Heyman Transactivation by Retinoid X Receptor-Peroxisome Proliferator-Activated Receptor gamma (PPARgamma ) Heterodimers: Intermolecular Synergy Requires Only the PPARgamma Hormone-Dependent Activation Function Mol. Cell. Biol., June 1, 1998; 18(6): 3483 - 3494. [Abstract] [Full Text] |
||||
![]() |
B. Couette, S. Jalaguier, C. Hellal-Levy, B. Lupo, J. Fagart, G. Auzou, and M.-E. Rafestin-Oblin Folding Requirements of the Ligand-Binding Domain of the Human Mineralocorticoid Receptor Mol. Endocrinol., June 1, 1998; 12(6): 855 - 863. [Abstract] [Full Text] |
||||
![]() |
P. B. Joel, A. M. Traish, and D. A. Lannigan Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase J. Biol. Chem., May 22, 1998; 273(21): 13317 - 13323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wood, G. L. Greene, and A. M. Nardulli Estrogen Response Elements Function as Allosteric Modulators of Estrogen Receptor Conformation Mol. Cell. Biol., April 1, 1998; 18(4): 1927 - 1934. [Abstract] [Full Text] |
||||
![]() |
J. D. Norris, D. Fan, M. R. Stallcup, and D. P. McDonnell Enhancement of Estrogen Receptor Transcriptional Activity by the Coactivator GRIP-1 Highlights the Role of Activation Function 2 in Determining Estrogen Receptor Pharmacology J. Biol. Chem., March 20, 1998; 273(12): 6679 - 6688. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Kraus and J. T. Kadonaga p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation Genes & Dev., February 1, 1998; 12(3): 331 - 342. [Abstract] [Full Text] |
||||
![]() |
P. H. Giangrande, G. Pollio, and D. P. McDonnell Mapping and Characterization of the Functional Domains Responsible for the Differential Activity of the A and B Isoforms of the Human Progesterone Receptor J. Biol. Chem., December 26, 1997; 272(52): 32889 - 32900. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Grese, J. P. Sluka, H. U. Bryant, G. J. Cullinan, A. L. Glasebrook, C. D. Jones, K. Matsumoto, A. D. Palkowitz, M. Sato, J. D. Termine, et al. Molecular determinants of tissue selectivity in estrogen receptor modulators PNAS, December 9, 1997; 94(25): 14105 - 14110. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Gehm, J. M. McAndrews, P.-Y. Chien, and J. L. Jameson Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor PNAS, December 9, 1997; 94(25): 14138 - 14143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Ozers, J. J. Hill, K. Ervin, J. R. Wood, A. M. Nardulli, C. A. Royer, and J. Gorski Equilibrium Binding of Estrogen Receptor with DNA Using Fluorescence Anisotropy J. Biol. Chem., November 28, 1997; 272(48): 30405 - 30411. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Modarress, J. Opoku, M. Xu, N. J. Sarlis, and S. S. Simons Jr. Steroid-induced Conformational Changes at Ends of the Hormone-binding Domain in the Rat Glucocorticoid Receptor Are Independent of Agonist Versus Antagonist Activity J. Biol. Chem., September 19, 1997; 272(38): 23986 - 23994. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Willson, J. D. Norris, B. L. Wagner, I. Asplin, P. Baer, H. R. Brown, S. A. Jones, B. Henke, H. Sauls, S. Wolfe, et al. Dissection of the Molecular Mechanism of Action of GW5638, a Novel Estrogen Receptor Ligand, Provides Insights into the Role of Estrogen Receptor in Bone Endocrinology, September 1, 1997; 138(9): 3901 - 3911. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Xiao and D. B. DeFranco Overexpression of Unliganded Steroid Receptors Activates Endogenous Heat Shock Factor Mol. Endocrinol., August 1, 1997; 11(9): 1365 - 1374. [Abstract] [Full Text] |
||||
![]() |
G. Lazennec, T. R. Ediger, L. N. Petz, A. M. Nardulli, and B. S. Katzenellenbogen Mechanistic Aspects of Estrogen Receptor Activation Probed with Constitutively Active Estrogen Receptors: Correlations with DNA and Coregulator Interactions and Receptor Conformational Changes Mol. Endocrinol., August 1, 1997; 11(9): 1375 - 1386. [Abstract] [Full Text] |
||||
![]() |
P. de Lange, J. W. Koper, N. A. T. M. Huizenga, A. O. Brinkmann, F. H. de Jong, M. Karl, G. P. Chrousos, and S. W. J. Lamberts Differential Hormone-Dependent Transcriptional Activation and -Repression by Naturally Occurring Human Glucocorticoid Receptor Variants Mol. Endocrinol., July 1, 1997; 11(8): 1156 - 1164. [Abstract] [Full Text] |
||||
![]() |
C. L. Smith, Z. Nawaz, and B. W. OMalley Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-Hydroxytamoxifen Mol. Endocrinol., June 1, 1997; 11(6): 657 - 666. [Abstract] [Full Text] |
||||
![]() |
J. D. Norris, D. Fan, S. A. Kerner, and D. P. McDonnell Identification of a Third Autonomous Activation Domain within the Human Estrogen Receptor Mol. Endocrinol., June 1, 1997; 11(6): 747 - 754. [Abstract] [Full Text] |
||||
![]() |
M. Nichols, J. M. J. Rientjes, C. Logie, and A. F. Stewart FLP Recombinase/Estrogen Receptor Fusion Proteins Require the Receptor D Domain for Responsiveness to Antagonists, but not Agonists Mol. Endocrinol., June 1, 1997; 11(7): 950 - 961. [Abstract] [Full Text] |
||||
![]() |
W. P. Bocchinfuso and K. S. Korach Estrogen Receptor Residues Required for Stereospecific Ligand Recognition and Activation Mol. Endocrinol., May 1, 1997; 11(5): 587 - 594. [Abstract] [Full Text] |
||||
![]() |
B. J. Cheskis, S. Karathanasis, and C. R. Lyttle Estrogen Receptor Ligands Modulate Its Interaction with DNA J. Biol. Chem., April 25, 1997; 272(17): 11384 - 11391. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. J. M. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, S. Nilsson, and J.-A. Gustafsson Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors {alpha} and {beta} Endocrinology, March 1, 1997; 138(3): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Liu, E. D. Collins, A. W. Norman, and S. Peleg Differential Interaction of 1alpha ,25-Dihydroxyvitamin D3 Analogues and Their 20-epi Homologues with the Vitamin D Receptor J. Biol. Chem., February 7, 1997; 272(6): 3336 - 3345. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lee and J. Gorski Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy PNAS, December 24, 1996; 93(26): 15180 - 15184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Louvion, R. Warth, and D. Picard Two eukaryote-specific regions of Hsp82 are dispensable for its viability and signal transduction functions in yeast PNAS, November 26, 1996; 93(24): 13937 - 13942. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. McInerney and B. S. Katzenellenbogen Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation J. Biol. Chem., September 27, 1996; 271(39): 24172 - 24178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Driscoll, C. L. Seachord, J. A. Lupisella, R. P. Darveau, and P. R. Reczek Ligand-induced Conformational Changes in the Human Retinoic Acid Receptor gamma Detected Using Monoclonal Antibodies J. Biol. Chem., September 20, 1996; 271(38): 22969 - 22975. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Oñate, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily Science, November 24, 1995; 270(5240): 1354 - 1357. [Abstract] [PDF] |
||||
![]() |
C. W. Kuil, C. A. Berrevoets, and E. Mulder Ligand-induced Conformational Alterations of the Androgen Receptor Analyzed by Limited Trypsinization J. Biol. Chem., November 17, 1995; 270(46): 27569 - 27576. [Abstract] [Full Text] [PDF] |
||||